Biopharmaceuticals represent another significant market segment, holding a dominant share of 44.2%. The increasing emphasis on biologics, gene therapies, and personalized medicine is fueling the ...
IDT and Elegen partner to launch an early access program offering long, clonal gene synthesis and high-complexity genes up to ...
The nucleosides are rich in exposed hydroxyl and amino groups, so scientists use protecting groups to prevent unintended reactions with compounds used in DNA synthesis. Chemicals remove the protecting ...
To write (store) data in this technology, DNA synthesis is required—creating DNA molecules based on the sequences encoding ...
Coralville-based Integrated DNA Technologies, a global leader in genomics solutions, has joined forces with Elegen, a leader in next-generation DNA ...
Matthew Hill, PhD, founder and CEO of Elegen, stated, “We are thrilled to partner with IDT, a long-standing leader in DNA synthesis. This collaboration allows Elegen to expand access to our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results